Ruboxistaurin a reality for reduced vision loss in diabetic retinopathy

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1552, 2006-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ruboxistaurin: reduced progression of diabetic retinopathy?

By  

Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Pericyte Loss in Diabetic Retinopathy: Mechanisms and Consequences

By  

Current Medicinal Chemistry, Vol. 20, Iss. 26, 2013-09 ,pp. : 3218-3225

Bentham Science Publishers

Access to resources Recommend Favorite

Ruboxistaurin provides hope in diabetic peripheral neuropathy

By  

Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss

By  

Current Neuropharmacology, Vol. 14, Iss. 8, 2016-11 ,pp. : 831-839

Bentham Science Publishers

Access to resources Recommend Favorite

The protein kinase C-β inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications

By Vinik Aaron  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1547-1559

Informa Healthcare

Access to resources Recommend Favorite